|
KMID : 1104820180060010016
|
|
Journal of Digestive Cancer Research
2018 Volume.6 No. 1 p.16 ~ p.24
|
|
|
Oncological Treatment of Advanced Gastric Cancer
|
|
Moon Hee-Seok
Jeong Hyun-Yong
|
|
|
Abstract
|
|
|
|
Gastric cancer is not a single, uniform disease, but rather heterogeneous in nature. It is generally not possible to cure patients with inoperable advanced or metastatic stomach cancer. In the absence of chemotherapy, the median survival time is 3 to 6 months. Therefore, several studies have confirmed the superiority of chemotherapy to the best supportive treatment, in terms of improving the quality of life and prolonging life. Various chemotherapies have been used in the past to treat advanced gastric cancer. Recently, various target therapies and immunotherapy have been introduced. However, compared to other malignancies, the quality of life and life expectancy remain relatively poor in patients with gastric cancer. We expect to overcome these difficulties in the future, with better elucidation of the molecular biology of gastric cancer.
|
|
|
KEYWORD
|
|
|
Stomach cancer, Chemotherapy, Target therapy, Immunotherapy
|
|
|
FullTexts / Linksout information
|
|
|
|
|
|
Listed journal information
|
|
|
|
|